AMZN vs FATE · P/E 31, rev $716.92B vs rev $3.4M
Amazon.com Inc (AMZN) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. FATE currently screens at market cap $331.0M.
Not investment advice. Open the AMZN and FATE stock pages for the full models.
Not investment advice.